Question 48

(Multiple Choice)

A researcher has coated the wells in a multiwell plate with human plasma fibronectin. She introduces integrin-expressing cells into these wells in the presence of different concentrations of a synthetic peptide. She then washes the wells to remove unbound cells and counts the number of cells that remain attached to each well. The results of her experiment are presented in the following schematic graph. The synthetic peptide sequences used in these experiments were GRGDSPC (1) or GGDRSLN (2). Which one of these peptides (1 or 2) would you expect to correspond to curve a in the graph? Which curve (a or b) would you expect if a synthetic peptide with the sequence GDGRSPC was used? C is cysteine, D is aspartic acid, G is glycine, L is leucine, N is asparagine, P is proline, R is arginine, and S is serine. A researcher has coated the wells in a multiwell plate with human plasma fibronectin. She introduces integrin-expressing cells into these wells in the presence of different concentrations of a synthetic peptide. She then washes the wells to remove unbound cells and counts the number of cells that remain attached to each well. The results of her experiment are presented in the following schematic graph. The synthetic peptide sequences used in these experiments were GRGDSPC (1) or GGDRSLN (2). Which one of these peptides (1 or 2) would you expect to correspond to curve a in the graph? Which curve (a or b) would you expect if a synthetic peptide with the sequence GDGRSPC was used? C is cysteine, D is aspartic acid, G is glycine, L is leucine, N is asparagine, P is proline, R is arginine, and S is serine.   A) 1; a B) 1; b C) 2; a D) 2; b


A) 1; a
B) 1; b
C) 2; a
D) 2; b

Answer